These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 18637442)
1. [Prognostic molecular markers in oral and lip squamous cell carcinoma--evaluation of expression and its significance]. Jaworska M; Kołosza Z; Liszka J; Nikiel B; Goleń M; Lange D; Scierski W; Namysłowski G Otolaryngol Pol; 2008; 62(2):175-81. PubMed ID: 18637442 [TBL] [Abstract][Full Text] [Related]
2. Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma. Perisanidis C; Perisanidis B; Wrba F; Brandstetter A; El Gazzar S; Papadogeorgakis N; Seemann R; Ewers R; Kyzas PA; Filipits M J Oral Pathol Med; 2012 Jan; 41(1):40-6. PubMed ID: 21883486 [TBL] [Abstract][Full Text] [Related]
3. p53, Ki67 and cyclin D1 as prognosticators of lymph node metastases in laryngeal carcinoma. Mielcarek-Kuchta D; Olofsson J; Golusinski W Eur Arch Otorhinolaryngol; 2003 Nov; 260(10):549-54. PubMed ID: 14551784 [TBL] [Abstract][Full Text] [Related]
4. Cyclin D1 expression in transitional cell carcinoma of the bladder: correlation with p53, waf1, pRb and Ki67. Tut VM; Braithwaite KL; Angus B; Neal DE; Lunec J; Mellon JK Br J Cancer; 2001 Jan; 84(2):270-5. PubMed ID: 11161387 [TBL] [Abstract][Full Text] [Related]
5. Predicting the effect of accelerated fractionation in postoperative radiotherapy for head and neck cancer based on molecular marker profiles: data from a randomized clinical trial. Suwinski R; Jaworska M; Nikiel B; Grzegorz W; Bankowska-Wozniak M; Wojciech M; Krzysztof S; Dariusz L Int J Radiat Oncol Biol Phys; 2010 Jun; 77(2):438-46. PubMed ID: 19733016 [TBL] [Abstract][Full Text] [Related]
6. Overexpression of cyclin D1 and interaction between p27Kip1 and tumour thickness predict lymph node metastases occurrence in lower lip squamous cell carcinoma. Rodolico V; Aragona F; Cabibi D; Di Bernardo C; Di Lorenzo R; Gebbia N; Gulotta G; Leonardi V; Ajello F Oral Oncol; 2005 Mar; 41(3):268-75. PubMed ID: 15743689 [TBL] [Abstract][Full Text] [Related]
7. Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance. Carlos de Vicente J; Herrero-Zapatero A; Fresno MF; López-Arranz JS Oral Oncol; 2002 Apr; 38(3):301-8. PubMed ID: 11978554 [TBL] [Abstract][Full Text] [Related]
8. Cyclin D1 and p16INK4A expression predict reduced survival in carcinoma of the anterior tongue. Bova RJ; Quinn DI; Nankervis JS; Cole IE; Sheridan BF; Jensen MJ; Morgan GJ; Hughes CJ; Sutherland RL Clin Cancer Res; 1999 Oct; 5(10):2810-9. PubMed ID: 10537346 [TBL] [Abstract][Full Text] [Related]
9. Assessment of laminin-5 in oral dysplasia and squamous cell carcinoma. Rani V; McCullough M; Chandu A J Oral Maxillofac Surg; 2013 Nov; 71(11):1873-9. PubMed ID: 23891017 [TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical and FISH analysis of EGFR and its prognostic value in patients with oral squamous cell carcinoma. Gröbe A; Eichhorn W; Fraederich M; Kluwe L; Vashist Y; Wikner J; Smeets R; Simon R; Sauter G; Heiland M; Blessmann M J Oral Pathol Med; 2014 Mar; 43(3):205-10. PubMed ID: 24020871 [TBL] [Abstract][Full Text] [Related]
11. Basal Ki67 expression measured by digital image analysis is optimal for prognostication in oral squamous cell carcinoma. Klimowicz AC; Bose P; Nakoneshny SC; Dean M; Huang L; Chandarana S; Magliocco AM; Wayne Matthews T; Brockton NT; Dort JC Eur J Cancer; 2012 Sep; 48(14):2166-74. PubMed ID: 22892062 [TBL] [Abstract][Full Text] [Related]
12. Ki-67, cyclin D1, p53 and bcl-2 expression in advanced head and neck cancer. Nagy B; Tiszlavicz L; Eller J; Molnar J; Thurzo L In Vivo; 2003; 17(1):93-6. PubMed ID: 12655798 [TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 overexpression in primary hypopharyngeal carcinomas. Masuda M; Hirakawa N; Nakashima T; Kuratomi Y; Komiyama S Cancer; 1996 Aug; 78(3):390-5. PubMed ID: 8697381 [TBL] [Abstract][Full Text] [Related]
14. [Assessment tumor markers by immunohistochemistry (Ki67, p53 and Bcl-2) on a cohort of patients with cervical cancer in various stages of evolution]. Stoenescu TM; Ivan LD; Stoenescu N; Azoicăi D Rev Med Chir Soc Med Nat Iasi; 2011; 115(2):485-92. PubMed ID: 21870745 [TBL] [Abstract][Full Text] [Related]
15. The relationship of the histologic grade at the deep invasive front and the expression of Ki-67 antigen and p53 protein in oral squamous cell carcinoma. Kurokawa H; Zhang M; Matsumoto S; Yamashita Y; Tanaka T; Tomoyose T; Takano H; Funaki K; Fukuyama H; Takahashi T; Sakoda S J Oral Pathol Med; 2005 Nov; 34(10):602-7. PubMed ID: 16202080 [TBL] [Abstract][Full Text] [Related]
16. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study. Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424 [TBL] [Abstract][Full Text] [Related]
17. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma. Nemes JA; Nemes Z; Márton IJ J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070 [TBL] [Abstract][Full Text] [Related]
18. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21(Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Ioachim E; Michael M; Stavropoulos NE; Kitsiou E; Hastazeris K; Salmas M; Stefanaki S; Agnantis NJ Urol Int; 2004; 73(1):65-73. PubMed ID: 15263796 [TBL] [Abstract][Full Text] [Related]
19. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma. Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375 [TBL] [Abstract][Full Text] [Related]
20. Cyclin D1 is a possible predictor of sensitivity to chemoradiotherapy for esophageal squamous cell carcinoma. Samejima R; Kitajima Y; Yunotani S; Miyazaki K Anticancer Res; 1999; 19(6C):5515-21. PubMed ID: 10697609 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]